K. Kaszala et al., MODIFICATION BY BRADYKININ B-2 RECEPTOR BLOCKADE OF PROTECTION BY PACING AGAINST ISCHEMIA-INDUCED ARRHYTHMIAS, European journal of pharmacology, 328(1), 1997, pp. 51-60
In dogs, rapid cardiac pacing, by way of a pacing electrode in the rig
ht ventricle, protects against ventricular arrhythmias when a coronary
artery is occluded immediately after cessation of the pacing period.
This represents a form of ischaemic preconditioning. The role of brady
kinin in mediating the protective effects of rapid cardiac pacing in t
his model was investigated using a selective antagonist of bradykinin
at B-2 receptors (icatibant; HOE 140). Ln the presence of icatibant ca
rdiac pacing (220 beats min(-1)) resulted in more severe ischaemia (as
assessed by ST-segment elevation from the pacing electrode at the end
of the stimulus) and to a higher incidence of ventricular arrhythmias
during the pacing protocol. When the coronary artery was occluded und
er such conditions the antiarrhythmic protection afforded by cardiac p
acing was not seen although other indices of reduced ischaemia severit
y (epicardial ST-segment mapping; changes in the degree of inhomogenei
ty of electrical activation within the ischaemic area) were not affect
ed by icatibant treatment. These results suggest that bradykinin is an
important trigger mediator involved in the protective effects of card
iac pacing. Whether this is due to the generation of endothelium-deriv
ed protective substances (such as nitric oxide and prostacyclin) or wh
ether it results from a direct effect on B-2 receptors in cardiac myoc
ytes is unclear.